Article

[Prevalence of dysphosphoremia in patients admitted in intensive care unit with an impaired renal function].

Département d'anesthésie-réanimation chirurgicale, hôpital Antoine-Béclère, 157, rue de la porte-de-Trivaux, université Paris-Sud, 92140 Clamart, France.
Annales Françaises d Anesthésie et de Réanimation (impact factor: 0.84). 07/2005; 24(7):791-4. DOI:10.1016/j.annfar.2005.04.007 pp.791-4
Source: PubMed

ABSTRACT To assess the frequency of dysphosphoremia in patients admitted in intensive care unit with an impaired renal function and to determine the associated risks factors. Study design. - Epidemiological prospective study.
The creatinine clearance and the phosphoremia were measured in 134 consecutive patients admitted in intensive care unit over a six-month period. Patients with chronic renal failure were excluded. Known risk factors for hypophosphoremia in intensive care unit were recorded.
Seventy-nine out of one hundred thirty-four patients (59%) had an impaired renal function (arbitrarily defined by a creatinine clearance < 60 ml/min). The proportion of patients with impaired renal function that where hypo-, normo- (0.8 to 1.2 mmol/l) or hyperphosphoremic was 16, 34 and 50% respectively. Hypophosphoremia was severe (< 0.5 mmol/l) in 5 patients, all with impaired renal function. No risk factors usually associated with hypophosphoremia could be identified.
As opposed to chronic renal failure patients who are mainly hyperphosphoremic, patients admitted in intensive care unit with an impaired renal function may present with a normo-, or hypophosphoremia. These dysphosphoremias are sometimes severe. Phosphate status should be promptly determined at admission.

0 0
 · 
0 Bookmarks
 · 
19 Views

Keywords

134 consecutive patients
 
5 patients
 
associated risks factors
 
chronic renal failure
 
chronic renal failure patients
 
creatinine clearance
 
Epidemiological prospective study
 
hundred thirty-four patients
 
hypophosphoremia
 
impaired renal function
 
intensive care unit
 
Known risk factors
 
normo-
 
patients
 
Phosphate status
 
six-month period
 

L M Joly